Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121584) titled 'An Open-label, Randomized Controlled Phase II Clinical Study of [18F]AlF-NOTA-FAPI-04 PET Combined with MRI-DWI Guided Spatially Fractionated Radiotherapy (Lattice SFRT) Compared to Conventional Fractionated Radiotherapy for Advanced Lung Cancer' on April 1.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shandong First Medical University and Shandong Academy of Medical Sciences (Shandong Cancer Hospital &Institute)
Condition:
Advanced bulky lung cancer
Intervention:
Lattice SFRT group:Lattice radiotherapy guided by [18F]AlF-NOTA-FAPI-04 PET/CT combined with DWI-MRI
Recruitment S...